Human umbilical-cord-blood mononucleated cells enhance the survival of lethally irradiated mice: Dosage and the window of time

Olga A. Kovalenko, Edouard I. Azzam, Norman Ende

Research output: Contribution to journalArticlepeer-review

5 Scopus citations

Abstract

The purpose of this study was to evaluate the window of time and dose of human umbilical-cord-blood (HUCB) mononucleated cells necessary for successful treatment of radiation injury in mice. Female A/J mice (27-30 weeks old) were exposed to an absorbed dose of 9-10 Gy of 137Cs γ-rays delivered acutely to the whole body. They were treated either with 1 × 108 or 2 × 108 HUCB mononucleated cells at 24-52 h after the irradiation. The antibiotic Levaquin was applied 4 h postirradiation. The increased dose of cord-blood cells resulted in enhanced survival. The enhancement of survival in animals that received 2 × 108 HUCB mononucleated cells relative to irradiated but untreated animals was highly significant (P < 0.01). Compared with earlier studies, the increased dose of HUCB mononucleated cells, coupled with early use of an antibiotic, extended the window of time for effective treatment of severe radiation injury from 4 to 24-52 h after exposure.

Original languageEnglish (US)
Pages (from-to)1010-1014
Number of pages5
JournalJournal of Radiation Research
Volume54
Issue number6
DOIs
StatePublished - Nov 2013

All Science Journal Classification (ASJC) codes

  • Radiation
  • Radiology Nuclear Medicine and imaging
  • Health, Toxicology and Mutagenesis

Keywords

  • Acute lethal total-body irradiation
  • Antibiotics
  • Human umbilical-cord blood
  • Radiation mass casualties

Fingerprint Dive into the research topics of 'Human umbilical-cord-blood mononucleated cells enhance the survival of lethally irradiated mice: Dosage and the window of time'. Together they form a unique fingerprint.

Cite this